Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Morphic Holding Inc
(NQ:
MORF
)
56.99
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Morphic Holding Inc
< Previous
1
2
3
Next >
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
August 06, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFC, HMNF, MORF on Behalf of Shareholders
July 31, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
July 29, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, COFS, PFC, WSBC on Behalf of Shareholders
July 27, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGR, MORF, DRQ, SHCR on Behalf of Shareholders
July 24, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, HUDA, ALE, DOMA on Behalf of Shareholders
July 23, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHCR, MORF on Behalf of Shareholders
July 20, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF
July 19, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, MORF on Behalf of Shareholders
July 11, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, INFN, AMBC, BEST on Behalf of Shareholders
July 10, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF
July 09, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion – InsideArbitrage
July 09, 2024
Via
AB Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, MORF, AGR on Behalf of Shareholders
July 08, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)
July 08, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
MORF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Morphic Holding, Inc. Is Fair to Shareholders
July 08, 2024
From
Halper Sadeh LLC
Via
Business Wire
Morphic to Participate in Jefferies Global Healthcare Conference
May 31, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells
May 21, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic to Participate in RBC Capital Markets Global Healthcare Conference
May 09, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
April 25, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
April 02, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 26, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF)
March 20, 2024
From
Abraham, Fruchter & Twersky, LLP
Via
GlobeNewswire
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
March 19, 2024
Experienced Clinical Development Leader with Deep Experience in Immunology and Inflammatory Diseases
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic to Participate in March Investor Conferences
March 05, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
February 22, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
January 11, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
January 10, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
January 04, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors
December 01, 2023
From
Robbins LLP
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.